Rafferty Asset Management
HUMA icon

Rafferty Asset Management’s Humacyte HUMA Stock Holding History

Rafferty Asset Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-185,258
Closed -$387K – 1118
2025
Q2 		$387K Buy
185,258
+262
+0.1% +$503 ﹤0.01% 929
2025
Q1 		$315K Sell
184,996
-46,056
-20% -$173K ﹤0.01% 951
2024
Q4 		$1.17M Sell
231,052
-15,947
-6% -$78.9K ﹤0.01% 761
2024
Q3 		$1.34M Buy
246,999
+142,703
+137% +$941K ﹤0.01% 730
2024
Q2 		$501K Buy
+104,296
New +$543K ﹤0.01% 938

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Rafferty Asset Management's HUMA Position: Q3 2025 in Review

Rafferty Asset Management sold out of Humacyte (HUMA) in Q3 2025, closing a stake of 185,258 shares — an estimated $387K sold.

Rafferty Asset Management first reported a position in HUMA in Q2 2024 and held it in 5 quarters. The position peaked at $1.34M in Q3 2024. 141 funds tracked by Wall St. Rank hold HUMA as of Q3 2025.

  • Rafferty Asset Management reported no remaining Humacyte position as of Q3 2025 after selling out during the quarter.
  • Rafferty Asset Management sold 185,258 Humacyte shares in Q3 2025, an estimated $387K.
  • Rafferty Asset Management first reported a position in Humacyte in Q2 2024 and held it in 5 quarters.
  • Rafferty Asset Management's Humacyte position peaked at $1.34M in Q3 2024.
  • 141 funds tracked by Wall St. Rank held Humacyte as of Q3 2025.

Based on Rafferty Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.